Items where Author is "Rakha, EA"
![]() | Up a level |
Journal article
ELSHARAWY, K.A., TOSS, M.S., RAAFAT, S., BALL, G., GREEN, A.R., ALESKANDARANY, M.A., DALTON, L.W. and RAKHA, E.A., 2020. Prognostic significance of nucleolar assessment in invasive breast cancer. Histopathology, 76 (5), pp. 671-684. ISSN 0309-0167
ABDEL-FATAH, T.M.A., ALI, R., SADIQ, M., MOSELEY, P.M., MESQUITA, K.A., BALL, G., GREEN, A.R., RAKHA, E.A., CHAN, S.Y.T. and MADHUSUDAN, S., 2019. ERCC1 is a predictor of anthracycline resistance and taxane sensitivity in early stage or locally advanced breast cancers. Cancers, 11 (8): 1149. ISSN 2072-6694
RAKHA, E.A., ALESKANDARANI, M., TOSS, M.S., GREEN, A.R., BALL, G., ELLIS, I.O. and DALTON, L.W., 2018. Breast cancer histologic grading using digital microscopy: concordance and outcome association. Journal of Clinical Pathology. ISSN 0021-9746
MARTIN, S.G., LEBOT, M.N., SUKKARN, B., BALL, G., GREEN, A.R., RAKHA, E.A., ELLIS, I.O. and STORR, S.J., 2018. Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients. Oncotarget, 9 (40), pp. 25946-25956. ISSN 1949-2553
RAKHA, E.A., AGARWAL, D., GREEN, A.R., ASHANKYTY, I., ELLIS, I.O., BALL, G. and ALASKANDARANY, M.A., 2017. Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer. Histopathology, 70 (4), pp. 622-631. ISSN 0309-0167
ARORA, A., PARVATHANENI, S., ALESKANDARANY, M.A., AGARWAL, D., ALI, R., ABDEL-FATAH, T., GREEN, A.R., BALL, G.R., RAKHA, E.A., ELLIS, I.O., SHARMA, S. and MADHUSUDAN, S., 2017. Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers. Molecular Cancer Therapeutics, 16 (1), pp. 239-250. ISSN 1535-7163
ALESKANDARANY, M.A., AGARWAL, D., NEGM, O.H., BALL, G., ELMOUNA, A., ASHANKYTY, I., NUGLOZEH, E., FAZALUDEEN, M.F., DIEZ-RODRIGUEZ, M., NOLAN, C.C., TIGHE, P.J., GREEN, A.R., ELLIS, I.O. and RAKHA, E.A., 2016. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts. Breast Cancer Research and Treatment, 156 (1), pp. 9-20. ISSN 0167-6806
GREEN, A.R., SORIA, D., STEPHENS, J., POWE, D.G., NOLAN, C.C., KUNKLER, I., THOMAS, J., KERR, G.R., JACK, W., CAMERON, D., PIPER, T., BALL, G.R., GARIBALDI, J.M., RAKHA, E.A., BARTLETT, J.M.S. and ELLIS, I.O., 2016. Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series. The Journal of Pathology: Clinical Research, 2 (1), pp. 32-40. ISSN 2056-4538
ARORA, A., ABDEL-FATAH, T.M.A., AGARWAL, D., DOHERTY, R., CROTEAU, D.L., MOSELEY, P.M., HAMEED, K., GREEN, A., ALESKANDARANY, M.A., RAKHA, E.A., PATTERSON, K., BALL, G., CHAN, S.Y.T., ELLIS, I.O., BOHR, V.A., BRYANT, H.E. and MADHUSUDAN, S., 2016. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers. Carcinogenesis, 37 (1), pp. 63-71. ISSN 0143-3334
GALE, K.L., RAKHA, E.A., BALL, G., TAN, V.K., MCCULLEY, S.J. and MACMILLAN, R.D., 2015. A Case-Controlled Study of the Oncologic Safety of Fat Grafting. Plastic and Reconstructive Surgery, 135 (5), pp. 1263-1275. ISSN 0032-1052
ALBARAKATI, N., ABDEL-FATAH, T.M.A., DOHERTY, R., RUSSELL, R., AGARWAL, D., MOSELEY, P., PERRY, C., ARORA, A., ALSUBHI, N., SEEDHOUSE, C., RAKHA, E.A., GREEN, A., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O. and MADHUSUDAN, S., 2015. Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy. Molecular Oncology, 9 (1), pp. 204-217. ISSN 1574-7891
ARORA, A., ABDEL-FATAH, T.M.A., AGARWAL, D., DOHERTY, R., MOSELEY, P.M., ALESKANDARANY, M.A., GREEN, A.R., BALL, G., ALSHAREEDA, A.T., RAKHA, E.A., CHAN, S.Y.T., ELLIS, I.O. and MADHUSUDAN, S., 2015. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer. Molecular Cancer Therapeutics, 14 (4), pp. 1057-1065. ISSN 1535-7163
GREEN, A.R., POWE, D.G., RAKHA, E.A., SORIA, D., LEMETRE, C., NOLAN, C.C., BARROS, F.F.T., MACMILLAN, R.D., GARIBALDI, J.M., BALL, G.R. and ELLIS, I.O., 2013. Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers. British Journal of Cancer, 109 (7), pp. 1886-1894. ISSN 0007-0920
BAKER, B.G., BALL, G.R., RAKHA, E.A., NOLAN, C.C., CALDAS, C., ELLIS, I.O. and GREEN, A.R., 2013. Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer. Breast Cancer Research and Treatment, 137 (1), pp. 127-137. ISSN 0167-6806
SULTANA, R., ABDEL-FATAH, T., ABBOTTS, R., HAWKES, C., ALBARAKATA, N., SEEDHOUSE, C., BALL, G., CHAN, S., RAKHA, E.A., ELLIS, I.O. and MADHUSUDAN, S., 2013. Targeting XRCC1 deficiency in breast cancer for personalized therapy. Cancer Research, 73 (5), pp. 1621-1634. ISSN 1538-7445
ALESKANDARANY, M.A., NEGM, O.H., RAKHA, E.A., AHMED, M.A.H., NOLAN, C.C., BALL, G.R., CALDAS, C., GREEN, A.R., TIGHE, P.J. and ELLIS, I.O., 2012. TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome. Breast Cancer Research and Treatment, 136 (2), pp. 419-427. ISSN 0167-6806
HABASHY, H.O., POWE, D.G., STAKA, C.M., RAKHA, E.A., BALL, G., GREEN, A.R., ALESKANDARANY, M., PAISH, E.C., MACMILLAN, R.D., NICHOLSON, R.I., ELLIS, I.O. and GEE, J.M.W., 2010. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Research and Treatment, 119 (2), pp. 283-293. ISSN 0167-6806
HABASHY, H.O., POWE, D.G., RAKHA, E.A., BALL, G., MACMILLAN, R.D., GREEN, A.R. and ELLIS, I.O., 2010. The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast Cancer Research and Treatment, 120 (3), pp. 603-612. ISSN 0167-6806
ZHANG, H., RAKHA, E.A., BALL, G.R., SPITERI, I., ALESKANDARANY, M., PAISH, E.C., POWE, D.G., MACMILLAN, R.D., CALDAS, C., ELLIS, I.O. and GREEN, A.R., 2010. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer. Breast Cancer Research and Treatment, 121 (1), pp. 41-51. ISSN 0167-6806
ELSHEIKH, S.E., GREEN, A.R., RAKHA, E.A., POWE, D.G., AHMED, R.A., COLLINS, H.M., SORIA, D., GARIBALDI, J.M., PAISH, C.E., AMMAR, A.A., GRAINGE, M.J., BALL, G.R., ABDELGHANY, M.K., MARTINEZ-POMARES, L., HEERY, D.M. and ELLIS, I.O., 2009. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Research, 69 (9), pp. 3802-3809. ISSN 0008-5472
HABASHY, H.O., POWE, D.G., RAKHA, E.A., BALL, G., PAISH, C., GEE, J., NICHOLSON, R.I. and ELLIS, I.O., 2008. Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. European Journal of Cancer, 44 (11), pp. 1541-1551. ISSN 0959-8049